A story in the BBC reports on the expected shift in human embryonic stem cell research policy under the incoming Obama administration. Many scientists are hopeful that he will lift the restrictive 2001 ban on certain cell lines, while others hope to see an infusion of cash and increased policy to support true bench-to-bedside research. "The impact of eight years under the previous administration for stem cell research has really been devastating," says Tom Okarma, head of stem cell company Geron.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

A genome-wide association study highlights a potential role for hair follicles in acne risk, according to New Scientist.

Newsday reports that breast cancer genetic testing guidelines for are out of date and may miss individuals.

In Cell this week: gene editing-based strategy to screen for immune system regulators, ancient plague patterns, and more.

Publication of He Jiankui's work on gene-edited infants would raise ethical concerns for journals, Wired and others report.